B of A Securities Maintains Buy on Boston Scientific, Raises Price Target to $100
Portfolio Pulse from Benzinga Newsdesk
B of A Securities has maintained a Buy rating on Boston Scientific and raised its price target from $90 to $100, indicating confidence in the company's future performance.
October 22, 2024 | 5:54 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
B of A Securities has reaffirmed its Buy rating on Boston Scientific and increased the price target to $100, suggesting positive expectations for the company's stock performance.
The reaffirmation of a Buy rating and an increase in the price target from $90 to $100 by B of A Securities indicates a positive outlook on Boston Scientific's future performance. This is likely to boost investor confidence and could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100